Yvonne Ang

An International Real-World Analysis of the Efficacy and Safety of Lorlatinib Through Early or Expanded Access Programs in Patients With Tyrosine Kinase Inhibitor–Refractory ALK-Positive or ROS1-Positive NSCLC

Viola W. Zhu, Yen-Ting Lin, Dong‐Wan Kim et al. · Journal of Thoracic Oncology · 2020 · 67 citations · Full text

Medicine, Oncology, Pharmacology +14

Low‐dose pembrolizumab in the treatment of advanced non‐small cell lung cancer

Jia Li Low, Yiqing Huang, Kenneth Sooi et al. · International Journal of Cancer · 2021 · 60 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +12

Noninvasive and invasive ventilation in acute respiratory failure associated with bronchiectasis

Jason Phua, Yvonne Ang, Kay Choong See et al. · Intensive Care Medicine · 2010 · 45 citations

Medicine, Clinical Sciences, Internal Medicine +14

Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases

Daryl Kai Ann Chia, Raghav Sundar, Guowei Kim et al. · Annals of Surgical Oncology · 2022 · 44 citations

Medicine, Oncology, Surgery +17

Risk factors for immune‐related adverse events from <scp>anti‐PD</scp>‐1 or anti‐<scp>PD‐L1</scp> treatment in an Asian cohort of nonsmall cell lung cancer patients

Yiqing Huang, Yu Yang Soon, Folefac Aminkeng et al. · International Journal of Cancer · 2021 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17